NCT07447960

LRFN5 and OLFM4 in Schizoaffective Disorder

CompletedOBSERVATIONAL

Trial Details

Start: 2026-03-02Est. Completion: 2026-06-02

Enrollment target: 110 participants

Locations

Elazığ Mental Health and Diseases Hospital Psychiatry Clinic, Elâzığ, Elâzığ, Turkey (Türkiye)

Other microbiome trials you might be interested in

FEEL-GOOD: A Multicenter Trial of a Mindfulness-Based Group Therapy in Young Adults With Early PsychosisRecruiting

Delusional DisorderBrief Psychotic DisorderSchizophreniform DisorderSchizophrenia / Schizoaffective DisorderOther Psychotic Disorder Not Due to A Substance or Known Physiological Condition

FEEL-GOOD is a prospective multi-site single-blinded randomized controlled trial in young inpatients with acute early ps…

Mannheim, GermanyEst. completion Sep 1, 2028

View Trial →

Gabapentin for Restoring GABA/Glutamate Homeostasis in Co-occurring Bipolar and Cannabis Use DisordersPhase 2Completed

Bipolar DisorderCannabis UseSchizoaffective Disorder, Bipolar TypeBipolar I Disorder

Apply or Learn More on ClinicalTrials.gov

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.